Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Lyell Immunopharma (LYEL) Shares Outstanding (Weighted Average): 2020-2025

Historic Shares Outstanding (Weighted Average) for Lyell Immunopharma (LYEL) over the last 5 years, with Sep 2025 value amounting to $19.2 million.

  • Lyell Immunopharma's Shares Outstanding (Weighted Average) rose 50.09% to $19.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.2 million, marking a year-over-year increase of 50.09%. This contributed to the annual value of $14.0 million for FY2024, which is 9.89% up from last year.
  • As of Q3 2025, Lyell Immunopharma's Shares Outstanding (Weighted Average) stood at $19.2 million, which was up 30.10% from $14.8 million recorded in Q2 2025.
  • Lyell Immunopharma's Shares Outstanding (Weighted Average)'s 5-year high stood at $19.2 million during Q3 2025, with a 5-year trough of $12.0 million in Q2 2021.
  • For the 3-year period, Lyell Immunopharma's Shares Outstanding (Weighted Average) averaged around $13.7 million, with its median value being $12.8 million (2024).
  • Per our database at Business Quant, Lyell Immunopharma's Shares Outstanding (Weighted Average) declined by 0.97% in 2021 and then skyrocketed by 50.09% in 2025.
  • Quarterly analysis of 5 years shows Lyell Immunopharma's Shares Outstanding (Weighted Average) stood at $12.0 million in 2021, then grew by 3.68% to $12.5 million in 2022, then increased by 1.91% to $12.7 million in 2023, then increased by 9.89% to $14.0 million in 2024, then surged by 50.09% to $19.2 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $19.2 million for Q3 2025, versus $14.8 million for Q2 2025 and $14.8 million for Q1 2025.